From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
The new facility marks Align’s first manufacturing presence in India and its fourth globally
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial
More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
